Keywords: positive, phase, data, medicure, iv, mc-1, flagship

Positive Phase I data for Medicure's IV MC-1

Article | 27 September 2004

Print This

Medicure's flagship drug MC-1, a naturally-occurring small molecule, has successfully completed a Phase I trial to evaluate its safety and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in